Positron emission tomography imaging in nonmalignant thoracic disorders

A Alavi, N Gupta, JL Alberini, M Hickeson… - Seminars in nuclear …, 2002 - Elsevier
The role of the fluorodeoxyglucose (FDG) technique positron emission tomography (PET) is
well established in the management of patients with lung cancer. Increasingly, it is becoming …

Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders

H Zhuang, QY Jian, A Alavi - Radiologic Clinics, 2005 - radiologic.theclinics.com
Fluorodeoxyglucose-PET (FDG-PET) has evolved into one of the major imaging modalities
commonly used in the management of a variety of malignancies [1, 2]. This application …

Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model

A van Waarde, DCP Cobben… - Journal of Nuclear …, 2004 - jnm.snmjournals.org
Increased glucose metabolism of inflammatory tissues is the main source of false-positive
18F-FDG PET findings in oncology. It has been suggested that radiolabeled nucleosides …

FDG PET in the evaluation of treatment for lymphoma: clinical usefulness and pitfalls

T Kazama, SC Faria, V Varavithya, S Phongkitkarun… - Radiographics, 2005 - pubs.rsna.org
Positron emission tomography (PET) with 2-[fluorine-18] fluoro-2-deoxy-d-glucose (FDG)
may play an important role in the evaluation and management of malignant lymphoma. FDG …

Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring …

A Mavi, P Lakhani, H Zhuang, NC Gupta… - Radiologic …, 2005 - radiologic.theclinics.com
Radiologic imaging modalities play a critical role in the diagnosis and the overall
management of many pulmonary disorders, including solitary pulmonary nodules, lung …

PET: a revolution in medical imaging

A Alavi, P Lakhani, A Mavi, JW Kung… - Radiologic …, 2004 - radiologic.theclinics.com
The discovery of the X ray by Roentgen in 1895 provided a method to visualize anatomic
structures in a living body. This event was one of the most striking episodes in the history of …

Demonstration of increased FDG activity in Rosai-Dorfman disease on positron emission tomography

QY Jian, H Zhuang, Y **u, E Talati… - Clinical nuclear …, 2004 - journals.lww.com
Rosai-Dorfman disease, or sinus histiocytosis with massive lymphadenopathy, is a rare
benign disease of unknown etiology that most commonly involves the cervical lymph nodes …

Radiation-induced esophagitis on FDG PET imaging

P Bhargava, P Reich, A Alavi… - Clinical nuclear …, 2003 - journals.lww.com
Whole-body fluorodeoxyglucose positron emission tomographic (FDG PET) imaging is now
being used for staging and restaging patients with a variety of cancers. Benign and …

Iatrogenic artifacts on whole-body F-18 FDG PET imaging

P Bhargava, H Zhuang, R Kumar… - Clinical nuclear …, 2004 - journals.lww.com
Purpose: Whole-body F-18 FDG PET images frequently show artifacts related to medical
and surgical interventions. We present some of the common artifact patterns in this atlas …

Normal variants in [18F]-fluorodeoxyglucose PET imaging

G El-Haddad, A Alavi, A Mavi, G Bural… - Radiologic …, 2004 - radiologic.theclinics.com
Since the introduction of [18F]-fluorodeoxyglucose PET (FDG-PET) in 1976, it has evolved
from a research imaging modality to become a powerful tool improving the management of …